Research / Impaact 2036
Impaact 2036
Pediatric HIV
Phase I/II Study of the Safety, Tolerability, Pharmacokinetics, and antiviral activity of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed HIV-Infected
Pediatric HIV